| P50 | author | Martin Steinmetz | Q79983109 |
| P2093 | author name string | Sebastian Zimmer | |
| | Dieter Lütjohann | |
| | Georg Nickenig | |
| | Catharina Lahrmann | |
| | Tobias Asdonk | |
| | Enzo Lüsebrink | |
| | Alexander O Krogmann | |
| P2860 | cites work | Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. | Q51030792 |
| | Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice. | Q53072350 |
| | Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. | Q53587595 |
| | Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. | Q54105529 |
| | Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice. | Q54292231 |
| | Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model. | Q54306542 |
| | Activation of Endothelial Toll-Like Receptor 3 Impairs Endothelial Function | Q56998027 |
| | Blocking Toll-Like Receptors 7 and 9 Reduces Postinterventional Remodeling via Reduced Macrophage Activation, Foam Cell Formation, and Migration | Q63915472 |
| | CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen | Q74463505 |
| | Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9 | Q80492358 |
| | Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity | Q36990647 |
| | Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in mice | Q37019912 |
| | Toll-like receptors in atherosclerosis: a 'Pandora's box' of advances and controversies | Q38153941 |
| | CpG ODN activates NO and iNOS production in mouse macrophage cell line (RAW 264.7). | Q38288131 |
| | Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration | Q38345478 |
| | HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9. | Q39057962 |
| | Stimulatory type A CpG-DNA induces a Th2-like response in human endothelial cells | Q39494483 |
| | Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation | Q40173384 |
| | Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity | Q40524997 |
| | Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution | Q41265554 |
| | Bacterial DNA signatures in carotid atherosclerosis represent both commensals and pathogens of skin origin | Q42275172 |
| | The activation of liver X receptors inhibits toll-like receptor-9-induced foam cell formation | Q43202380 |
| | Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways | Q44807760 |
| | Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock | Q44931090 |
| | A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation | Q46346484 |
| | The Toll-like receptor 9 ligand CPG-C attenuates acute inflammatory cardiac dysfunction | Q48884290 |
| | A Toll-like receptor recognizes bacterial DNA | Q24290668 |
| | Toll-like receptor 9 protects non-immune cells from stress by modulating mitochondrial ATP synthesis through the inhibition of SERCA2 | Q24338906 |
| | Danger signaling in atherosclerosis | Q26852204 |
| | Cholesterol, inflammation and innate immunity | Q28086912 |
| | Toll-like receptor 9-activation during onset of myocardial ischemia does not influence infarct extension | Q28541982 |
| | The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling | Q29615457 |
| | Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor | Q30747560 |
| | CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs | Q33343610 |
| | Toll-like receptor 9 mediated responses in cardiac fibroblasts | Q34050642 |
| | Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells | Q34083770 |
| | CpG motifs in bacterial DNA trigger direct B-cell activation | Q34307394 |
| | Systemic inflammation and liver injury following hemorrhagic shock and peripheral tissue trauma involve functional TLR9 signaling on bone marrow-derived cells and parenchymal cells. | Q34400381 |
| | Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. | Q35015661 |
| | Microbial composition of atherosclerotic plaques | Q35031446 |
| | The TRAF-associated protein TANK facilitates cross-talk within the IkappaB kinase family during Toll-like receptor signaling | Q35345969 |
| | The immunobiology of the TLR9 subfamily | Q35810913 |
| | The toll-like receptor 9 agonist, CpG-oligodeoxynucleotide 1826, ameliorates cardiac dysfunction after trauma-hemorrhage | Q36103464 |
| | Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation | Q36370469 |
| | CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling | Q36456832 |
| | TLR9 in health and disease | Q36526346 |
| | In vivo TLR9 inhibition attenuates CpG-induced myocardial dysfunction | Q36830961 |
| | Selective roles for toll-like receptors 2, 4, and 9 in systemic inflammation and immune dysfunction following peripheral tissue injury. | Q36896481 |
| | The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling | Q36957263 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| | toll-like receptor | Q408004 |
| P304 | page(s) | e0146326 | |
| P577 | publication date | 2016-01-11 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Proinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice | |
| P478 | volume | 11 | |